BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
7/28/16 Pfizer (PFE) Xeljanz/Xeljanz XR for Ulcerative Colitis (UC) Subscribers Only Subscribers Only Subscribers Only
7/28/16 Adaptimmune (ADAP) NY-ESO-1(C259) for Sarcoma Subscribers Only Subscribers Only Subscribers Only
7/28/16 Caladrius Biosciences (CLBS) CLBS03 for Diabetes Mellitus, Type I Subscribers Only Subscribers Only Subscribers Only
7/28/16 Sanofi (SNY) Adlyxin for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
7/27/16 BioMarin (BMRN) Brineura for Neuronal Ceroid Lipofuscinosis (NCL) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
07/29/16 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
07/29/16 Subscribers Only Subscribers Only Trial Data - Updated Results
07/29/16 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
07/29/16 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
07/29/16 Subscribers Only Subscribers Only Company - Earnings Announcement